Search

everythinglearnresearchcommunity

for

Search:↓

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Neurosteroids can influence behavior by modulating brain inhibition, with potential for treating psychiatric disorders.

Flow cytometry was effective in diagnosing metastatic breast cancer in a bone marrow sample.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

Gut flora changes could potentially indicate depression, but more research is needed.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Most women with depression in the study had low vitamin D levels.

The conclusion is that the risk of losing significance in meta-analysis results increases with smaller effects and more missing data, and using the median standard deviation for imputation is recommended.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

The document suggests using natural remedies like bloodletting and honey for various health issues but lacks scientific evidence for their effectiveness.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

Nursing women in the West Bank with higher income and non-smoking habits have higher blood zinc levels.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Good nutrition is crucial for health and preventing disease, and supplements can help prevent nutrient deficiencies.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

Early detection and treatment of iron deficiency in pregnancy are crucial for maternal and infant health.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.